What is CytomX Therapeutics's deemed dividend on warrants?

CytomX Therapeutics (CTMX) reported deemed dividend on warrants of -$750.5K in Q4 2025.

What does deemed dividend on warrants mean?

This represents the non-cash accounting charge resulting from the modification or issuance of warrants that are classified as equity instruments. It reflects the economic value attributed to warrant holders that reduces the earnings available to common shareholders. Investors monitor this to understand the dilutive impact and non-operating adjustments affecting net income attributable to common stockholders.

CytomX Therapeutics CTMX Deemed Dividend On Warrants

Deemed Dividend On Warrants at other companies

ATN InternationalATNI

$1.1M+129%

IDEAYA Biosciences, Inc.IDYA

$0—

Taysha Gene Therapies, Inc.TSHA

$409.25K—

XER

Xeris Biopharma Holdings, Inc.XERS

$7.33M—

Monte Rosa Therapeutics, Inc.GLUE

$0-100%

NextNavNN

-$2.25M—

Other financials

Income statement

See full

Revenue$10.3M-79.9%

Operating income-$19.7M-187%

Net income-$18.2M-178%

EPS (diluted)-$0.10-137%

Balance sheet

See full

Cash & equivalents$28.8M-39.4%

Total debt$2.9M-65.0%

Total equity$319.9M+1,177%

Total assets$359.4M+265%

Cash flow

See full

Operating cash flow-$25.5M-21.4%

CapEx--100%

Free cash flow-$25.5M-20.7%

Valuation

See full

Market cap$711.89M+94.8%

Enterprise value$685.92M+110%

P/S20×+17.6×

Profitability

See full

Operating margin-181.9%-206pp

Net margin-166.4%-195pp

FCF margin-225.6%-334pp

Returns & leverage

See full

Return on equity-34.3%—

Debt / equity0×-0.3×

Current ratio10.4×+8.7×

Where this comes from

Reported directly by CytomX Therapeutics in its filing.

Tagged under the XBRL concept ctmx:DeemedDividendOnWarrants.

The official record: CytomX Therapeutics’s 10-K, filed March 16, 2026, on SEC EDGAR. View the filing →

Ask your AI about CytomX Therapeutics's deemed dividend on warrants.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is CytomX Therapeutics's deemed dividend on warrants?: CytomX Therapeutics (CTMX) reported deemed dividend on warrants of -$750.5K in Q4 2025.
What does deemed dividend on warrants mean?: This represents the non-cash accounting charge resulting from the modification or issuance of warrants that are classified as equity instruments. It reflects the economic value attributed to warrant holders that reduces the earnings available to common shareholders. Investors monitor this to understand the dilutive impact and non-operating adjustments affecting net income attributable to common stockholders.